Justin J. File's Net Worth
$978 Thousand
Who is Justin J. File?
Justin J. File does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Evofem Biosciences, Inc., and MEI Pharma, Inc..
SEC CIK
Justin J. File's CIK is 0001726277
Past Insider Trading and Trends
2018 was Justin J. File's most active year for acquiring shares with 7 total transactions. Justin J. File's most active month to acquire stocks was the month of January. 2019 was Justin J. File's most active year for disposing of shares, totalling 8 transactions. Justin J. File's most active month to dispose stocks was the month of October. 2020 saw Justin J. File paying a total of $63,566.86 for 270,106 shares, this is the most they've acquired in one year. In 2018 Justin J. File cashed out on 119,510 shares for a total of $293,994.60, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Evofem Biosciences, Inc. (EVFM) Snapshot price: $0.03
Chief Financial OfficerJustin J. File owns 810,982 units of Common Stock which is worth $24,329.46. From 2018 to 2022 Justin J. File acquired a total of 1,235,200 shares in Evofem Biosciences, Inc. at a cost of $103,821.64, Justin also disposed a total of 428,521 shares of Evofem Biosciences, Inc. equalling to $1,057,007.94.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +124.66% | 450K |
—
|
—
| 810.98K |
Feb 18
| |||
Form 4
| -24.95% | -120.00K |
—
|
—
| 360.98K |
Dec 31
| |||
Form 4
| +9.22% | 40.59K |
$0.37 | $15,019.78 | 480.98K |
Dec 20
| |||
Form 4
| +5.89% | 24.5K |
$1.03 | $25,235.00 | 440.39K |
Jun 10
| |||
Form 4
| -9.23% | -42.28K |
$0.86 | -$36,360.80 | 415.89K |
May 20
| |||
Form 4
| +77.47% | 200K |
—
|
—
| 458.17K |
Feb 3
| |||
Form 4
| +3.10% | 7.76K |
$2.17 | $16,839.20 | 258.17K |
Nov 17
| |||
Form 4
| +3.51% | 8.5K |
$3.14 | $26,690.00 | 250.41K |
Jun 12
| |||
Form 4
| -15.27% | -42.81K |
$3.31 | -$141,701.10 | 237.6K |
Jun 5
| |||
Form 4
| -13.10% | -42.26K |
$4.99 | -$210,887.38 | 280.42K |
May 22
| |||
Form 4
| -2.54% | -8.42K |
$5.24 | -$44,120.80 | 322.68K |
May 6
| |||
Form 4
| +86.80% | 153.85K |
$5.21 | $20,037.66 | 331.1K |
Feb 5
| |||
Form 4
| -0.92% | -1.65K |
$6.00 | -$9,888.00 | 177.25K |
Scheduled
|
Jan 13
| ||
Form 4
| -1.84% | -3.35K |
$6.05 | -$20,279.60 | 178.9K |
Scheduled
|
Jan 2
| ||
Form 4
| -5.20% | -10.00K |
$7.16 | -$71,600.00 | 182.25K |
Scheduled
|
Dec 2
| ||
Form 4
| -4.99% | -10.10K |
$6.22 | -$62,834.44 | 192.25K |
Nov 25
| |||
Form 4
| -6.94% | -15.10K |
$5.83 | -$87,985.48 | 202.35K |
Scheduled
|
Nov 20 - Nov 21
| ||
Form 4
| -0.71% | -1.56K |
$5.13 | -$7,992.54 | 217.46K |
Aug 22
| |||
Form 4
| -4.44% | -10.19K |
$6.36 | -$64,776.60 | 219.01K |
Jun 10
| |||
Form 4
| -0.56% | -1.29K |
$3.55 | -$4,586.60 | 229.2K |
Apr 1
| |||
Form 4
| +27.70% | 50K |
—
|
—
| 230.49K |
Feb 25
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Nov 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 31
| |||
Form 4
|
∞
| 180.49K |
$2.46 | -$293,994.60 | 180.49K |
Jul 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MEI Pharma, Inc. (MEIP) Snapshot price: $4.52
CFO and Corporate Secretary
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||